Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative clinical performance of two types of drug-eluting stents with abluminal biodegradable polymer coating: Five-year results of the DESTINY randomized trial.
Prado GFA Jr, Abizaid AAC, Meireles GC, Sarmento-Leite R, Prudente M, Cantarelli M, Dourado AD, Jr JM, Perin MA, Costantini C, Costa R, Costa JR, Chamie D, Campos CM, Ribeiro EE, Lemos PA. Prado GFA Jr, et al. Among authors: ribeiro ee. Rev Port Cardiol (Engl Ed). 2021 Feb;40(2):71-76. doi: 10.1016/j.repc.2020.05.017. Epub 2021 Jan 2. Rev Port Cardiol (Engl Ed). 2021. PMID: 33402278 Free article. Clinical Trial. English, Portuguese.
Late clinical outcomes after implantation of drug-eluting stents coated with biodegradable polymers: 3-year follow-up of the PAINT randomised trial.
Lemos PA, Moulin B, Perin MA, Oliveira LA, Arruda JA, Lima VC, Lima AA, Caramori PR, Medeiros CR, Barbosa MR, Brito FS Jr, Ribeiro EE. Lemos PA, et al. Among authors: ribeiro ee. EuroIntervention. 2012 May 15;8(1):117-9. doi: 10.4244/EIJV8I1A18. EuroIntervention. 2012. PMID: 22580255 Free article. Clinical Trial.
Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial.
Lemos PA, Moulin B, Perin MA, Oliveira LA, Arruda JA, Lima VC, Lima AA, Caramori PR, Medeiros CR, Barbosa MR, Brito FS Jr, Ribeiro EE, Martinez EE; PAINT trial investigators. Lemos PA, et al. Among authors: ribeiro ee. Catheter Cardiovasc Interv. 2009 Nov 1;74(5):665-73. doi: 10.1002/ccd.22166. Catheter Cardiovasc Interv. 2009. PMID: 19670303 Clinical Trial.
Rationale and design for the PAINT randomized trial.
Lemos PA, Moulin B, Perin MA, Oliveira LA, Arruda JA, Lima VC, Lima AA, Caramori PR, Medeiros CR, Barbosa MR, Brito FS Jr, Ribeiro EE, Martinez EE; PAINT study. Lemos PA, et al. Among authors: ribeiro ee. Arq Bras Cardiol. 2009 Dec;93(6):547-53, 590-7. doi: 10.1590/s0066-782x2009001200006. Arq Bras Cardiol. 2009. PMID: 20379631 Free article. Clinical Trial. English, Portuguese.
Very late outcomes of drug-eluting stents coated with biodegradable polymers: insights from the 5-year follow-up of the randomized PAINT trial.
Marchini JF, Gomes WF, Moulin B, Perin MA, Oliveira LA, Arruda JA, Lima VC, Lima AA, Caramori PR, Medeiros CR, Barbosa MR, Brito FS Jr, Ribeiro EE, Lemos PA. Marchini JF, et al. Among authors: ribeiro ee. Cardiovasc Diagn Ther. 2014 Dec;4(6):480-6. doi: 10.3978/j.issn.2223-3652.2014.12.05. Cardiovasc Diagn Ther. 2014. PMID: 25610805 Free PMC article.
Four-year clinical follow-up of the first-in-man randomized comparison of a novel sirolimus eluting stent with abluminal biodegradable polymer and ultra-thin strut cobalt-chromium alloy: the INSPIRON-I trial.
Oliveira MD, Ribeiro EE, Campos CM, Ribeiro HB, Faillace BL, Lopes AC, Esper RB, Meirelles GX, Perin MA, Abizaid A, Lemos PA. Oliveira MD, et al. Among authors: ribeiro ee, ribeiro hb. Cardiovasc Diagn Ther. 2015 Aug;5(4):264-70. doi: 10.3978/j.issn.2223-3652.2015.07.05. Cardiovasc Diagn Ther. 2015. PMID: 26331110 Free PMC article.
Clinical performance of a novel ultrathin strut, low-dose, sirolimus-eluting stent with abluminal-only biodegradable polymeric coating for patients undergoing percutaneous coronary intervention in the daily practice.
Prado GF Jr, Ribeiro EE, Melo PH, Pinton FA, Esteves-Filho A, Takimura CK, Mariani J Jr, Kajita LJ, Marchiori G, Araripe Falcao Bde A, Galon MZ, Soares PR, Zalc S, Lemos PA. Prado GF Jr, et al. Among authors: ribeiro ee. Cardiovasc Diagn Ther. 2015 Dec;5(6):414-9. doi: 10.3978/j.issn.2223-3652.2015.07.07. Cardiovasc Diagn Ther. 2015. PMID: 26675281 Free PMC article.
Aspirin-Free Prasugrel Monotherapy Following Coronary Artery Stenting in Patients With Stable CAD: The ASET Pilot Study.
Kogame N, Guimarães PO, Modolo R, De Martino F, Tinoco J, Ribeiro EE, Kawashima H, Ono M, Hara H, Wang R, Cavalcante R, Moulin B, Falcão BAA, Leite RS, de Almeida Sampaio FB, Morais GR, Meireles GC, Campos CM, Onuma Y, Serruys PW, Lemos PA. Kogame N, et al. Among authors: ribeiro ee. JACC Cardiovasc Interv. 2020 Oct 12;13(19):2251-2262. doi: 10.1016/j.jcin.2020.06.023. Epub 2020 Sep 16. JACC Cardiovasc Interv. 2020. PMID: 32950419 Free article. Clinical Trial.
126 results